BioSpace News Archive

In response to the rapid escalation in COVID-19 related mental health issues, Espyr, an industry leader in mental health solutions, will begin offering its highly effective iResolve tele-mental health solution to help employers provide immediate support for employee mental health issues.

Ennaid Therapeutics, LLC, a specialty pharmaceutical company that uses its artificial intelligence (AI)-based drug discovery platforms to develop antiviral drugs, today announced that it is advanci

The National Center for Manufacturing Sciences (NCMS) is pleased to announce a new partnership with the Department of Defense (DOD) and the Federal Emergency Management Agency (FEMA) to support the critical shortage of medical equipment and supplies. Tapping into our significant network of American manufacturers, and working al

Voltron Therapeutics, Inc. announced today that it has entered into a Sponsored Research Agreement with the Vaccine and Immunotherapy Center (VIC) of the Massachusetts General Hospital (MGH).

The Healthcare Coalition for Emergency Preparedness reports that a California manufacturer of medical waste sterilization equipment, San-I-Pak, has been collaborating with local hospitals who have now tested and started sterilizing certain disposable Personal Protective Equipment with these large autoclaves already on-site.

The COVID-19 pandemic and the historic federal, state, and local government efforts to mitigate its spread has stopped the economy in its tracks

Oncology® and CancerNetwork®, a multispecialty platform focused on bringing practical, peer-reviewed content that can affect how oncologists, oncology nurses, and other relevant health care professionals treat their patients, are pleased to announce the appointment of Julie M. Vose, M.D., MBA, and Howard S. Hochster, M.D., FACP, as co-editors in chief of the journal Oncology®.

CMS guidelines for supplemental oxygen adjusted to protect patients during COVID-19 crisis

CureSearch for Children’s Cancer has committed $2.5 million to fund a first-in-human, phase I/II clinical trial testing an innovative personalized immunotherapy for pediatric high-grade gliomas, the primary cause of death in children with brain tumors.

The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis.